Contact this trialFirst, we need to learn more about you.
Virus Therapy
RSV Vaccine for Respiratory Syncytial Virus
Recruiting1 awardPhase 1
Rochester, New York
This trial is testing a new vaccine called RSVpreF in children aged 2 to under 18 years. The goal is to find a safe and effective dose that helps their immune system fight off the RSV virus. Participants will receive one injection and have several follow-up visits over a period of time.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service